Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Even with effective smoking cessation medications, many smokers are unable to abruptly stop using tobacco. This finding has increased interest in smoking reduction as an interim step towards complete cessation. METHODS: This multi-center, double-blind placebo-controlled study evaluated the efficacy and safety of nicotine 4 mg gum or nicotine 10 mg inhaler in helping smokers (N = 314) to reduce or quit smoking. It included smokers willing to control their smoking, and participants could set individual goals, to reduce or quit. The study was placebo-controlled, randomized in a ratio of 2:1 (Active:Placebo), and subjects could choose inhaler or gum after randomization. Outcome was short-term (from Week 6 to Month 4) and long-term (from Month 6 to Month 12) abstinence or reduction. Abstinence was defined as not a single cigarette smoked and expired CO readings of <10 ppm. Smoking reduction was defined as a reduction in number of cigarettes per day by 50% or more versus baseline, verified by a lower-than-baseline CO reading at each visit during the same periods. RESULTS: Significantly more smokers managed to quit in the Active group than in the Placebo group. Sustained abstinence rates at 4 months were 42/209 (20.1%) subjects in the Active group and 9/105 (8.6%) subjects in the Placebo group (p = 0.009). Sustained abstinence rates at 12 months were 39/209 (18.7%) and 9/105 (8.6%), respectively (p = 0.019). Smoking reduction did not differ between the groups, either at short-term or long-term. Twelve-month reduction results were 17.2% vs. 18.1%, respectively. No serious adverse events were reported. CONCLUSION: In conclusion, treatment with 10 mg nicotine inhaler or 4 mg nicotine chewing gum resulted in a significantly higher abstinence rate than placebo. In addition a large number of smokers managed to reduce their cigarette consumption by more than 50% compared to baseline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub3 · Cited by 721
The feasibility of smoking reduction: an update
Hughes, J. R., & Carpenter, M. J. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01174.x · Cited by 168 · cited 3×
“Smoking reduction could represent a first step towards cessation, since in reducing their cigarette consumption smokers experience a degree of success in controlling their smoking behavior and this can encourage subsequent quit attempts [2,4].”
BackgroundResultWennike, P., Danielsson, T., Landfeldt, B., Westin, Å., & Tønnesen, P. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00489.x · Cited by 163 · cited 5×
“This is not surprising, given the different study populations: our study invited smokers who wanted to control their smoking (in any way), whereas previous studies of NRT for smoking reduction specifically enrolled smokers unable or not motivated to quit [5-8].”
InfluentialAiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?
Fagerstrom, K. O., Tejding, R., Westin, A., & Lunell, E. (1997) · Tobacco Control · doi:10.1136/tc.6.4.311 · Cited by 133 · cited 1×
“Nicotine replacement therapy could also help smokers who are not able or willing to abruptly quit to reduce their smoking, by replacing some of the nicotine normally obtained from cigarettes [3].”
Background
Cited by
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Nicotine replacement therapy versus control for smoking cessation
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub5 · Cited by 697
Interventions for preventing weight gain after smoking cessation
Farley, A. C., Hajek, P., Lycett, D., & Aveyard, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006219.pub3 · Cited by 334
Interventions to reduce harm from continued tobacco use
Lindson-Hawley, N., Hartmann-Boyce, J., Fanshawe, T. R., Begh, R., Farley, A., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005231.pub3 · Cited by 273
Smoking reduction interventions for smoking cessation
Lindson, N., Klemperer, E., Hong, B., Ordóñez-Mena, J. M., & Aveyard, P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013183.pub2 · Cited by 133
Metadata
- Authors
- Kralikova, E., Kozak, J. T., Rasmussen, T., Gustavsson, G., & Le Houezec, J.
- Venue
- BMC Public Health
- Published
- 2009-11-27
- Volume
- 9
- Issue
- 1
- Pages
- 433-433
- ISSN
- 1471-2458 (ISSN-L)
- OpenAlex
- W2012042537
- Cited by
- 45
- References
- 4
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler. https://app.cochat.ai/papers/10.1186/1471-2458-9-433
- The paper
- Kralikova, E., Kozak, J. T., Rasmussen, T., Gustavsson, G., & Le Houezec, J. (2009). Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler. BMC Public Health. https://doi.org/10.1186/1471-2458-9-433
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.